Goldman Sachs Group »

Bright Minds Biosciences shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Bright Minds Biosciences (DRUG) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Bright Minds Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Bright Minds Biosciences held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bright Minds Biosciences by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $3.8M 49k 78.04
2025-03-31 $802k 22k 36.07

More positions owned by Goldman Sachs Group

Nvidia Corporation CMN (NVDA)
Apple CMN (AAPL)
Microsoft Corp CMN (MSFT)
Spdr S&p 500 Etf Tr CMN (SPY)
Tesla CMN (TSLA)
Alphabet CMN (GOOGL)
Amazon CMN (AMZN)
Broadcom CMN (AVGO)
Meta Platforms CMN (META)
Invesco Qqq Tr CMN (QQQ)
Vanguard Index Fds CMN (VOO)
Alphabet CMN (GOOG)
Ishares Tr CMN (IVV)
Eli Lilly & Co CMN (LLY)
Jpmorgan Chase & Co. CMN (JPM)

View all positions for Goldman Sachs Group

Top funds holding Bright Minds Biosciences

Henderson Group
Cormorant Asset Management
Vivo Capital
Perceptive Advisors
Adage Capital Partners GP
BlackRock
Braidwell
MPM Oncology Impact Management
Sio Capital Management
Balyasny Asset Management
Ikarian Capital
Eventide Asset Management
Stempoint Capital
Longwood Capital Partners
State Street Corporation

View all funds holding Bright Minds Biosciences